Middletown, DE -- (SBWIRE) -- 08/22/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: VelocityShares Daily Inverse VIX Short Term ETN (NYSEARCA:XIV), Hewlett-Packard Company (NYSE:HPQ), Pfizer Inc. (NYSE:PFE), iShares MSCI Brazil Index (ETF) (NYSEARCA:EWZ)
VelocityShares Daily Inverse VIX Short Term ETN (NYSEARCA:XIV) remained among the day decliners and traded with volume of 2.92 million shares in the last session. The stock on Wednesday decreased -1.88% and finished the day at $26.06. The 52 week range of the stock remained $13.34 - $29.00.
Has XIV Found The Bottom and Ready To Move Up? Find Out Here
Hewlett-Packard Company (NYSE:HPQ) opened at the price of $25.93, whereas its previous closing price was recorded at $25.38. HPQ plunged -1.78% and traded within the range of $25.24 - $26.04 for the day. The 52 week range of the stock remained in between $11.35 - $27.78. Hewlett-Packard Company and its subsidiaries provide products, technologies, software, solutions, and services to individual consumers, small-and medium-sized businesses (SMBs), and large enterprises, including customers in the government, health, and education sectors worldwide. Its Personal Systems segment offers commercial notebooks and desktops; consumer notebooks, desktops, and mini notebooks; and workstations, calculators and other related accessories, and software and services for the commercial and consumer markets. The company?s Services segment provides consulting, outsourcing, and technology services to infrastructure, applications, and business process domains.
Has HPQ Found The Bottom And Ready To Gain Momentum? Find Out Here
Pfizer Inc. (NYSE:PFE) ended its day with the loss of -1.02% and closed at the price of $28.24, after opening at $28.50. Stock traded during its last trading session with the total volume of 23.23 million shares, as compared to its average volume of 27.98 million shares. Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimers disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas.
Why Should Investors Buy PFE After the Recent Fall? Just Go Here and Find Out
iShares MSCI Brazil Index (ETF) (NYSEARCA:EWZ) reported the decrease of -2.04%, to close at $41.26, with the overall traded volume of 8.86 million shares. iShares MSCI Brazil Index (ETF) (NYSEARCA:EWZ) has the total of 122.30 million outstanding shares. iShares MSCI Brazil Capped Index Fund (the Fund), formerly iShares MSCI Brazil Index Fund, seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly traded securities in the Brazilian market, as measured by the MSCI Brazil Index (the Index). The Index seeks to measure the performance of the Brazilian equity market. It is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization.
Will EWZ Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)